Absorption: 0.6% absorbed following oral administration (significantly ↓ by food).
Distribution: Rapidly binds to bone.
Protein Binding: 90.999.5%.
Half-Life: PO: 1060 hr; IV: 4.625.5 hr.
Contraindicated in:
Use Cautiously in:
Derm: ERYTHEMA MULTIFORME, STEVENS-JOHNSON SYNDROME
GI: diarrhea, dyspepsia, dysphagia, ESOPHAGEAL CANCER, esophageal/gastric ulcer, esophagitis
Local: injection site reactions
MS: musculoskeletal pain, pain in arms/legs, femur fractures, osteonecrosis (primarily of jaw)
Resp: asthma exacerbation
Misc: ANAPHYLAXIS
Lab Test Considerations:
IV Administration: